Page last updated: 2024-08-24

imiquimod and Lymphoma

imiquimod has been researched along with Lymphoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, S; Lim, YT; Noh, HJ; Noh, YW; Shin, WJ; Um, SH	1
Beyeler, M; Burg, G; Dummer, R; Morcinek, J	1
Grossman, L; Mena, J; Miller, RL; Shi, Y; Sorrenti, V; Spaner, DE	1

Reviews

1 review(s) available for imiquimod and Lymphoma

Article	Year
[Cutaneous neoplasms]. Praxis, 2003, Sep-03, Volume: 92, Issue:36 Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors	2003

Article

Year

[Cutaneous neoplasms].

Praxis, 2003, Sep-03, Volume: 92, Issue:36

Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors

2003

Other Studies

2 other study(ies) available for imiquimod and Lymphoma

Article	Year
Hyaluronic acid-supported combination of water insoluble immunostimulatory compounds for anti-cancer immunotherapy. Carbohydrate polymers, 2017, Jan-02, Volume: 155 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cancer Vaccines; Drug Carriers; Female; Hyaluronic Acid; Hydrogen Bonding; Imiquimod; Immunotherapy; Lipid A; Lymphoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Saponins; Solubility	2017
Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod. Leukemia & lymphoma, 2005, Volume: 46, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome	2005

Article

Year

Hyaluronic acid-supported combination of water insoluble immunostimulatory compounds for anti-cancer immunotherapy.

Carbohydrate polymers, 2017, Jan-02, Volume: 155

Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cancer Vaccines; Drug Carriers; Female; Hyaluronic Acid; Hydrogen Bonding; Imiquimod; Immunotherapy; Lipid A; Lymphoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Saponins; Solubility

2017

Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod.

Leukemia & lymphoma, 2005, Volume: 46, Issue:6

Topics: Aged; Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome

2005